CONVERT PHARMACEUTICALS (Public limited company)
CONVERT PHARMACEUTICALS is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0671.828.631. It was founded on 24-02-2017. Its registered office is in Liège. Its main activity is: Scientific research and development. Its annual accounts for 2023 report 66197.7 full-time equivalents. Its annual accounts for 2025 report equity of € -841 823 and a loss of € 629 343. Addrly gives it a financial health grade of B, on a scale from A (safest) to E (most at risk). It filed its annual accounts within the legal deadline for each of its last 4 financial years.
Information last updated on 14-10-2026.
Company information
Key figures of CONVERT PHARMACEUTICALS
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
Profit / lossiWhat the period earned after taxes. A negative amount is a loss. | € -629 343+3 % | € -645 819-5 % | € -616 326-23 % | € -501 407 |
EquityiWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company. | € -841 823+28 % | € -1 164 977+18 % | € -1 414 510-77 % | € -798 184 |
Total assetsiEverything the company owns. Equal to total equity and liabilities, which says how it is financed. | € 941 204-23 % | € 1 216 454+241 % | € 357 154-66 % | € 1 039 225 |
Gross marginiSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else. | € -247 884+52 % | € -513 906-540 % | € -80 305 | € 78 406 |
Employees (FTE)iAverage number of workers over the period, in full-time equivalents. | - | - | 66197.7+22 065 800 % | 0.3 |
Financial estimate
- 1 Shareholders
Similar companies
Other companies in the same activity in Liège.
| Company | Town |
|---|---|
| Advanced Coatings & Construction Solutions | 4000 Liège |
| Inokura | 4000 Liège |
| ERAL TRADING | 4000 Liège |
| SOCIETE UNIVERSITAIRE DE PROMOTION DE LA RECHERCHE MEDICALE | 4000 Liège |
| MEDIXBEL | 4000 Liège |
| GABRIEL DELEU | 4000 Liège |
| TER-Consult | 4000 Liège |
| BIO-SOURCING | 4000 Liège |
Frequently asked questions
Is CONVERT PHARMACEUTICALS still active? Yes. The Crossroads Bank for Enterprises lists CONVERT PHARMACEUTICALS as active.
What is the VAT number of CONVERT PHARMACEUTICALS? The VAT number of CONVERT PHARMACEUTICALS is BE 0671.828.631.
When was CONVERT PHARMACEUTICALS founded? CONVERT PHARMACEUTICALS was founded on 24-02-2017.
What is the address of CONVERT PHARMACEUTICALS? The current registered office of CONVERT PHARMACEUTICALS is Esplanade Simone Veil 1, 4000 Liège.
When did CONVERT PHARMACEUTICALS last file annual accounts? The latest annual accounts of CONVERT PHARMACEUTICALS were filed on 17-06-2026.
Does CONVERT PHARMACEUTICALS file its annual accounts on time? Yes. CONVERT PHARMACEUTICALS filed its annual accounts within the legal deadline for each of its last 4 financial years.
How many employees does CONVERT PHARMACEUTICALS have? CONVERT PHARMACEUTICALS employs 66197.7 full-time equivalents according to its most recent annual accounts.
Is CONVERT PHARMACEUTICALS financially healthy? Addrly gives CONVERT PHARMACEUTICALS a financial health grade of B, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.
Is CONVERT PHARMACEUTICALS profitable? The annual accounts of CONVERT PHARMACEUTICALS for 2025 show a loss of € 629 343.
What is the equity of CONVERT PHARMACEUTICALS? The equity of CONVERT PHARMACEUTICALS was € -841 823 at the close of the 2025 financial year.
Can CONVERT PHARMACEUTICALS receive Peppol e-invoices? Yes. CONVERT PHARMACEUTICALS is registered on the Peppol network and can receive structured electronic invoices.
What does CONVERT PHARMACEUTICALS do? The main activity of CONVERT PHARMACEUTICALS is: Scientific research and development.